Experimental HCV protease inhibitor to receive fast track approval (Hep C Chronic Fatigue)

Experimental HCV protease inhibitor to receive fast track approval
Aidsmap - An experimental oral protease inhibitor for the treatment of hepatitis C virus has been granted fast track designation by the United States' Food and Drug Administration (FDA), the organisation that approves medicines for use in the US. The

AVI BioPharma Announces Hepatitis C Virus License Agreement with
dBusinessNews.com - Offering comprehensive Web design services to new economy enterprises across a wide range of platforms and technologies, Web Design Studio takes pride in delivering big-business Internet solutions to small and medium-sized businesses. PORTLAND -- AVI

Extrahepatic sites may cause rapid recurrence of Hepatitis C after
RxPG - "In most patients HCV RNA levels decreased rapidly during and after transplantation and subsequently began to increase reaching above pre-transplant levels in all but one patient within a few days of the procedure." By AASLD, When a diseased

SuperGen to buy Montigen Inc.
Contra Costa Times - SuperGen to buy Montigen Inc. SuperGen Inc. (SUPG) said it agreed to acquire privately held oncology drug developer Montigen Pharmaceuticals Inc. for $18 million in cash and stock. Under the terms of the agreement, Dublin-based SuperGen will pay